Ontology highlight
ABSTRACT:
INSTRUMENT(S): Illumina HiSeq 2000
ORGANISM(S): Homo sapiens
SUBMITTER: Frank Redegeld
PROVIDER: E-MTAB-11907 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Chen Jing J Zaal Esther A EA Berkers Celia R CR Ruijtenbeek Rob R Garssen Johan J Redegeld Frank A FA
Cells 20210902 9
Multiple myeloma (MM) is a hematological malignancy that exhibits aberrantly high levels of proteasome activity. While treatment with the proteasome inhibitor bortezomib substantially increases overall survival of MM patients, acquired drug resistance remains the main challenge for MM treatment. Using a combination treatment of docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) and bortezomib, it was demonstrated previously that pretreatment with DHA/EPA significantly increased bortezomib ...[more]